Stage IV Small Lymphocytic Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0028635 (Stage IV Small Lymphocytic Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00918723Vorinostat, Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTreatment